Changes in waist circumference and incidence of chronic kidney disease

Abstract

Changes in WC are not independent risk factors for CKD development in women, whereas waist gain can adversely influence the development of CKD in men.

Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: A longitudinal study in Taiwan

“…In line with the findings of the present study, results from two prospective studies of healthy men showed that men with a weight gain >10% (vs stable weight ±5%) or a weight gain ≥0.75 kg/year (vs stable weight −0.25 to <0.25 kg/year) had an increased risk of incident CKD. One large‐scale long‐term study, with a median follow‐up duration of 9 years, also found that severe waist gain ≥9 cm (vs stable waist ±2 cm) adversely affected the incidence of CKD in men . However, the exact cause of the gain in weight and WC is unclear in diabetic patients.…”

“…One large-scale long-term study, with a median follow-up duration of 9 years, also found that severe waist gain ≥9 cm (vs stable waist AE2 cm) adversely affected the incidence of CKD in men. 13 However, the exact cause of the gain in weight and WC is unclear in diabetic patients. Insulin therapy commonly results in weight gain, which can adversely affect cardiovascular risk factors.…”

“…A significant U‐shaped association between weight change and the risk of CKD has been observed after adjusting for baseline BMI . Waist increase was also found to be associated with the development of CKD in the general population . To the best of our knowledge, no studies have examined the effects of changes in weight and WC on the risk of developing CKD in patients with T2DM in the Asian population.…”

Predictors of incident obesity phenotype in nonobese healthy adults

“…Details of the study have been published elsewhere [12]. Details of the study have been published elsewhere [12].…”

“…Participants Subjects were recruited from among participants of the Tehran Lipid and Glucose Study (TLGS), an ongoing, populationbased, cohort study being conducted since 1999 among a representative urban Tehranian population. Details of the study have been published elsewhere [12]. In brief, the TLGS has two major components: Phase I, a cross-sectional prevalence study of noncommunicable diseases (1999)(2000)(2001) and associated risk factors, and a prospective follow-up study at 3-year intervals, that is phase II (2002)(2003)(2004)(2005), phase III (2006-2008), phase IV (2009-2011) and phase V (2012-2104).…”